Contact this trialFirst, we need to learn more about you.
Kinase Inhibitor
Savolitinib + Osimertinib for Lung Cancer
Recruiting0 awardsPhase 2
Brooklyn, New York
This trial will compare the effectiveness of savolitinib with osimertinib or a placebo in treating patients with lung cancer that has spread and who have already been treated with osimertinib.
Fill-in a few details and create your profileHaving a profile will help us send you recommended trials and speed up your application in the future.
We will keep your details privateWe won’t share unless you give us permission. By completing this form you agree to our privacy policy
Get in touch with the study teamWe’ll send your responses to the study team and help you to setup your first screening. This is not the start of informed consent. Screening happens between you and the trial.